EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute

Clement D Okello, Andrew W Shih, Martin Nabwana, Noah Kiwanuka, Nancy Heddle, Harriet Mayanja-Kizza, Jackson Orem

African Health Sciences · 27.12.2023 · 23 (4) · 362-370

DOI: 10.4314/ahs.v23i4.39 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift African Health Sciences, online erschienen am 27.12.2023. Verfasst von Clement D Okello und 6 weiteren Autor:innen. Beteiligte Einrichtung: Uganda Cancer Institute. Hauptthemen laut MEDLINE: Erythrocytes, Isoantibodies, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is limited data on red blood cell (RBC) alloimmunization in patients with cancer in sub-Saharan Africa (SSA). We examined the frequency of RBC alloimmunization in transfused patients with cancers in Uganda.

Methods

A randomized control trial was conducted on participants at the Uganda Cancer Institute. Eligible participants were age ≥15 years and required blood transfusion. Participants were randomized to receive either leucoreduced or non-leucoreduced blood transfusion. Participants’ plasma samples were screened for RBC alloantibodies at enrolment and 3-4 weeks after blood transfusion using a 2-cell panel of reagent group O RBCs using the tube method. Antibody identification was performed using a 10-cell panels of reagent RBCs. Participants were considered alloimmunized if antibodies to RBC antigens were identified.

Results

A total of 277 participants were randomized (leucoreduced blood, n=137; non-leucoreduced blood, n=140). Overall, the most represented diagnoses were gynaecological cancers (n=88, 31.8%), acute leukaemia (n=35, 12.6%), and gastrointestinal cancers (n=25, 9.0%). Concomitant HIV infection was present in 26 (9.4%) participants. Most participants received

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythrocytesIsoantibodiesNeoplasmsHumansUgandaFemaleMaleAdultMiddle AgedBlood TransfusionAgedTransfusion ReactionAdolescentYoung Adult

Stichwörter der Autor:innen

Allo-immunizationCancerUgandabloodtransfusion

Substanzen

Isoantibodies

Autor:innen und Institutionen

  • Uganda Cancer Institute.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Makerere University - Johns Hopkins University Research Collaboration.
  • School of Public Health, College of Health Sciences, Makerere University, Uganda.
  • McMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton ON, Canada.
  • Department of Medicine, College of Health Sciences, Makerere University, Uganda.

Zitieren

APA

Okello, C. D., Shih, A. W., Nabwana, M., Kiwanuka, N., Heddle, N., Mayanja-Kizza, H., & Orem, J. (2023). Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute. African Health Sciences, 23(4), 362-370. https://doi.org/10.4314/ahs.v23i4.39

Vancouver

Okello CD, Shih AW, Nabwana M, Kiwanuka N, Heddle N, Mayanja-Kizza H, et al. Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute. African Health Sciences. 2023;23(4):362-370. doi:10.4314/ahs.v23i4.39

BibTeX
@article{Okello2023,
  author = {Okello, Clement D and Shih, Andrew W and Nabwana, Martin and Kiwanuka, Noah and Heddle, Nancy and Mayanja-Kizza, Harriet and Orem, Jackson},
  title = {Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute},
  journal = {African Health Sciences},
  year = {2023},
  volume = {23},
  number = {4},
  pages = {362--370},
  doi = {10.4314/ahs.v23i4.39}
}
Kostenlos starten →